S-Network Biopharma M&A Index
An index of mid to large cap biotechnology and pharmaceutical stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials or year on year sales growth.
Quick Links
| As June 1, 2023 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
| Price Return | 5,891.8 | -3.1% | 2.4% | 19.1% | 0.6% |
| Total Return | |||||
| Net Total Return |
| Index Level | 5,891.8 |
|---|---|
| 3-Month | -3.1% |
| 6-Month | 2.4% |
| 1-Year | 19.1% |
| YTD | 0.6% |
| Index Level | |
|---|---|
| 3-Month | |
| 6-Month | |
| 1-Year | |
| YTD |
| Index Level | |
|---|---|
| 3-Month | |
| 6-Month | |
| 1-Year | |
| YTD |
As of June 1, 2023
Characteristics
| Index Symbol (Price Return) | PBMA |
| Index Symbol (Total Return) | NA |
| Index Symbol (Net Total Return) | PBMANTR |
| Number of Constituents | 127 |
| Market Capitalization | $579 Billion |
| Adjusted Market Capitalization | $106 Million |
| Rebalancings | Quarterly |
| Dividend Yield | 0.2% |
Resources
Composition
Top Index Constituents
As of June 1, 2023
Interested in Market Data packages?
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us